Scott-Macon Healthcare Review for Q3 2022
Providing our clients with senior level perspectives on corporate finance solutions in the healthcare industry.
Scott-Macon Healthcare Investment Banking Group presents our Healthcare Review for Q3 2022. The review includes expert insights from our senior professionals on:
- Examination of provider M&A trends over the last quarter
- Insights into current data and market valuations of public healthcare companies
Based on more 30 years of transaction experience, our publications containing senior level perspectives are aimed at creating and advocating solutions to our clients in the healthcare industry to help them make informed investment decisions.